<DOC>
	<DOCNO>NCT03085940</DOCNO>
	<brief_summary>Rheumatoid arthritis ( RA ) increase cardiovascular risk endothelial dysfunction . Hydroxychloroquine ( HCQ ) expect improve endothelial dysfunction metabolic effect . The investigator intend find role HCQ improve endothelial dysfunction RA patient . This study also evaluate correlation HOMA-IR ( homeostasis model assessment-estimated insulin resistance ) , FFA ( free fatty acid ) ox-LDL ( oxidized-LDL ) level change , endothelial dysfunction improvement .</brief_summary>
	<brief_title>Role Hydroxychloroquine Improve Endothelial Dysfunction Patients With Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Hydroxychloroquine</mesh_term>
	<criteria>Rheumatoid Arthritis patient ( 2010 ACR/EULAR criterion ) Being treat methotrexate ( monotherapy ) Agree join study Autoimmune diseases RA Acute severe infection , acute coronary syndrome , heart failure , stroke Malignancy chronic inflammatory disease Eye disease involve retina visual field defect G6PD ( glucose 6phosphate dehydrogenase ) deficiency History smoking within last 5 year Lipid lowering , insulin resistance lowering , antidiabetic , insulin , ACE ( angiotensin convert enzyme ) inhibitor ARB ( angiotensin receptor blocker ) drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>